Viewing StudyNCT05576077



Ignite Creation Date: 2024-05-06 @ 6:11 PM
Last Modification Date: 2024-10-26 @ 2:43 PM
Study NCT ID: NCT05576077
Status: RECRUITING
Last Update Posted: 2024-07-11
First Post: 2022-10-07

Brief Title: A Study of TBio-4101 TIL and Pembrolizumab in Patients With Advanced Solid Tumors
Sponsor: Turnstone Biologics Corp
Organization: Turnstone Biologics Corp

Conditions & Keywords Data

Conditions:
Name
Head and Neck Squamous Cell Carcinoma
Breast Cancer
Colorectal Cancer
Uveal Melanoma
Cutaneous Melanoma
Non-Small Cell Lung Cancer
Keywords:
Name View
ocular melanoma View
MSS-CRC View
TIL View
Tumor infiltrating lymphocyte View
TNBC View
HR Breast View
ER Breast View
MSI-CRC View
personalized medicine View